J protein mutations and resulting proteostasis collapse

Carolina Koutras1, Janice E A Braun1

  • 1Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary Calgary, AB, Canada.

Insights

Protein aggregation diseases are difficult to treat because cellular quality control fails. J proteins (DnaJ/Hsp40) are key chaperone cofactors and potential therapeutic targets for these proteostasis disorders.

Area of Science:

  • Molecular biology
  • Cellular biology
  • Protein folding

Background:

  • Protein aggregation diseases, such as Alzheimer's and Parkinson's, are a significant health burden.
  • Molecular chaperones normally maintain protein conformation, but their failure leads to disease.
  • The cellular chaperone network is complex, with specific chaperone functions not fully elucidated.

Purpose of the Study:

  • To review recent findings on mutations in J protein chaperones.
  • To highlight the role of J proteins in proteostasis collapse.
  • To identify J proteins as potential therapeutic targets for protein aggregation diseases.

Main Methods:

  • Literature review of studies on J protein mutations.
  • Analysis of the impact of these mutations on cellular proteostasis.
  • Examination of the interaction between J proteins and Hsc70.

Main Results:

  • Mutations in specific J protein chaperones are linked to proteostasis collapse.
  • J proteins, as cofactors for Hsc70, play a critical role in protein quality control.
  • Dysfunctional J proteins contribute to the pathogenesis of protein aggregation diseases.

Conclusions:

  • J proteins are crucial components of the cellular chaperone network.
  • Targeting J proteins offers a novel therapeutic strategy for protein aggregation diseases.
  • Further research into J protein function is warranted for clinical applications.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.7K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
11.9K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

3.5K
Protein Denaturation01:28

Protein Denaturation

The function of proteins depends on their native three-dimensional structure, which is dictated by the amino acid sequence of the specific protein. Folding of the polypeptide chain takes place under specific conditions that energetically favor the folded conformation. In contrast, protein denaturation occurs spontaneously under unfavorable conditions that disrupt the integrity of the folded conformation. Thus, the chemical and physical environment of a protein, such as significant changes in pH...
8.8K
Mutations01:39

Mutations

Overview
66.6K